| Literature DB >> 10963203 |
S N Wagner, V Rebmann, C P Willers, H Grosse-Wilde, M Goos.
Abstract
Individual predictive clinical, immunological, or molecular features for definition of patients with lymph-node-positive melanoma who do not benefit from adjuvant postsurgery high-dose interferon alpha treatment are lacking. Expression analysis of classic and non-classic HLA molecules on melanoma cells metastatic to the locoregional lymph node may help select these patients before treatment.Entities:
Mesh：
Substances：
Year: 2000 PMID： 10963203 DOI： 10.1016/S0140-6736(00)02486-7
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321